PP_1170x120_10-25-21

Centogene

Centogene extends partnership with Takeda

Centogene extends partnership with Takeda

CAMBRIDGE, Mass.— Centogene N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians, and pharmaceutical companies, has extended its partnership with Takeda Pharmaceutical Co. to diagnose patients with certain genetic disorders. As part of the agreement, which has been extended until March 2022, Centogene

Adheris Health